Britain's conditional authorization of Merck’s COVID-19 treatment pill gives the country another weapon in the fight against the pandemic.
Britain has granted conditional authorization to Merck’s COVID-19 pill — the only one so far shown to successfully treat the disease — becoming the first nation to OK the treatment, although it was not immediately clear how quickly the drug would be available.
“Today is a historic day for our country, as the U.K. is now the first country in the world to approve an antiviral that can be taken at home for COVID-19,” said Health Secretary Sajid Javid. . That’s roughly the same group targeted for treatment with infused COVID-19 antibody drugs, the standard of care in many countries for patients who don’t yet require hospitalization.A previous version of this story misstated when Merck issued findings regarding its COVID-19 pill. They were announced in September, not last month.
Britain’s Medicines and Healthcare Products Regulatory Agency said molnupiravir’s ability to interact with DNA and cause mutations had been studied “extensively” and that it was not found to pose a risk to humans. Molnupiravir was initially studied as a potential flu therapy with funding from the U.S. government. Last year, researchers at Emory University decided to re-purpose the drug as a potential COVID-19 treatment. They then licensed the drug to Ridgeback and its partner, Merck., in a move aimed at helping millions of people in poorer countries get access.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Britain approves Merck's COVID-19 pill in world firstBritain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
Weiterlesen »
An effective new drug to treat covid-19 emerges from MerckMolnupiravir has been approved by Britain’s national medicines regulatory agency—the first in the world to do so
Weiterlesen »
Analysis: Country by country, scientists eye beginning of an end to the COVID-19 pandemicAs the devastating Delta variant surge eases in many regions of the world, scientists are charting when, and where, COVID-19 will transition to an endemic disease in 2022 and beyond, according to Reuters interviews with over a dozen leading disease experts.
Weiterlesen »
Some Parents Rush to Get Covid-19 Vaccines for Young KidsYounger children began to get vaccinated against Covid-19 Wednesday, adding to the nation’s defenses against a pandemic that has upended learning and life for kids across three school years
Weiterlesen »
Pfizer COVID-19 vaccine now available for kids ages 5 to 11: 5 things to knowAn 8-year-old receives his vaccine—and gets a hug from Dr. Bear—at a Washington hospital. What to know as the Pfizer COVID-19 vaccine is now available for kids ages 5 to 11:
Weiterlesen »